Daesung Microbiological Labs. Co., Ltd. (KOSDAQ:036480)
South Korea · Delayed Price · Currency is KRW 5,210.00
-30.00 (-0.57%)
At close: Nov 13, 2026
KOSDAQ:036480 Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 12, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 19,798 | 27,740 | 34,542 | 41,610 | 39,140 | 54,530 | |
Market Cap Growth | -26.20% | -19.69% | -16.99% | 6.31% | -28.22% | -11.42% |
Enterprise Value | 30,072 | 39,613 | 47,686 | 54,480 | 47,642 | 67,675 |
Last Close Price | 5210.00 | 7300.00 | 8998.61 | 10752.02 | 10045.31 | 13893.76 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 12, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 56.44 | 46.37 | - | - | 22.98 | 62.97 |
PS Ratio | 0.79 | 1.07 | 1.45 | 1.63 | 1.54 | 2.27 |
PB Ratio | 0.57 | 0.78 | 0.98 | 1.11 | 1.01 | 1.47 |
P/TBV Ratio | 0.58 | 0.79 | 0.99 | 1.13 | 1.02 | 1.49 |
P/FCF Ratio | 32.11 | 26.31 | 26.41 | - | - | - |
P/OCF Ratio | 20.31 | 19.67 | 16.43 | - | 33.88 | 24.75 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 12, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 1.19 | 1.52 | 2.00 | 2.13 | 1.87 | 2.82 |
EV/EBITDA Ratio | 16.49 | 12.17 | 292.26 | 25.07 | 20.03 | 23.54 |
EV/EBIT Ratio | - | 55.46 | - | - | - | 200.75 |
EV/FCF Ratio | 48.78 | 37.57 | 36.47 | - | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 12, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.56 | 0.56 | 0.58 | 0.64 | 0.57 | 0.60 |
Debt / EBITDA Ratio | 10.37 | 6.14 | 125.20 | 11.05 | 9.26 | 7.77 |
Debt / FCF Ratio | 31.14 | 18.95 | 15.62 | - | - | - |
Net Debt / Equity Ratio | 0.30 | 0.30 | 0.32 | 0.33 | 0.24 | 0.34 |
Net Debt / EBITDA Ratio | 5.55 | 3.25 | 69.71 | 5.65 | 3.86 | 4.32 |
Net Debt / FCF Ratio | 16.67 | 10.04 | 8.70 | -4.93 | -7.91 | -16.24 |
Asset Turnover | 0.44 | 0.45 | 0.39 | 0.40 | 0.40 | 0.38 |
Inventory Turnover | 1.63 | 1.87 | 1.73 | 1.73 | 1.87 | 1.86 |
Quick Ratio | 1.74 | 1.71 | 2.87 | 1.54 | 1.51 | 2.44 |
Current Ratio | 3.51 | 2.96 | 5.22 | 2.76 | 2.70 | 4.46 |
Return on Equity (ROE) | 1.02% | 1.70% | -4.88% | -1.78% | 4.49% | 2.36% |
Return on Assets (ROA) | -0.72% | 0.77% | -1.58% | -0.66% | -0.32% | 0.34% |
Return on Invested Capital (ROIC) | -1.48% | 1.54% | -3.23% | -1.41% | -0.51% | 0.69% |
Return on Capital Employed (ROCE) | -1.30% | 1.40% | -2.90% | -1.30% | -0.60% | 0.60% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 12, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 1.77% | 2.16% | -5.12% | -1.63% | 4.35% | 1.59% |
FCF Yield | 3.11% | 3.80% | 3.79% | -5.98% | -2.96% | -1.40% |
Payout Ratio | 81.25% | 47.64% | - | - | 16.73% | 37.30% |